AnaptysBio (ANAB) Q3 2023 Earnings Report
MX:ANAB Q3 2023 EPS Results
- Actual EPS
- -MXN 17.47
- Consensus EPS
- -MXN 22.02
- Beat/Miss
- Beat by +MXN 4.55
- One Year Ago EPS
- -MXN 14.62
MX:ANAB Q3 2023 Revenue Results
- Actual Revenue
- MXN 61.65M
- Expected Revenue
- MXN 42.53M
- Beat/Miss
- Beat by +MXN 19.12M
- YoY Revenue Growth
- +156.61%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/02/2023
- Time
- After Close
- Conference Call
- Thursday, November 2, 2023
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q3 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -34.19-34.19 | 9.68 | -453.17% (-43.87) | ― |
| Sep 21, 2026 | 2026 (Q2) | -16.59-16.59 | -16.59 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.45-15.85 | -23.84 | 33.52% (+7.99) | |
| Mar 03, 2026 | 2025 (Q4) | -16.5929.41 | -8.92 | 429.79% (+38.33) | |
| Nov 04, 2025 | 2025 (Q3) | -15.859.68 | -14.12 | 168.55% (+23.80) | |
| Aug 06, 2025 | 2025 (Q2) | -8.92-24.92 | -21.18 | -17.63% (-3.73) | |
| May 05, 2025 | 2025 (Q1) | -14.12-23.84 | -20.31 | -17.38% (-3.53) | |
| Feb 27, 2025 | 2024 (Q4) | -20.05-8.92 | -19.7 | 54.72% (+10.78) | |
| Nov 05, 2024 | 2024 (Q3) | -20.40-14.12 | -17.47 | 19.15% (+3.34) | |
| Aug 05, 2024 | 2024 (Q2) | -12.90-21.18 | -18.58 | -14.00% (-2.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
